Erkin Musabaev

1.2k total citations
41 papers, 312 citations indexed

About

Erkin Musabaev is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Erkin Musabaev has authored 41 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hepatology, 20 papers in Epidemiology and 10 papers in Infectious Diseases. Recurrent topics in Erkin Musabaev's work include Hepatitis B Virus Studies (16 papers), Hepatitis C virus research (16 papers) and Liver Disease Diagnosis and Treatment (12 papers). Erkin Musabaev is often cited by papers focused on Hepatitis B Virus Studies (16 papers), Hepatitis C virus research (16 papers) and Liver Disease Diagnosis and Treatment (12 papers). Erkin Musabaev collaborates with scholars based in Uzbekistan, China and South Africa. Erkin Musabaev's co-authors include Roger I. Glass, Joseph Bresee, Masashi Mizokami, Yasuhito Tanaka, Lynn Antil, Fuat Kurbanov, Elmira T. Isakbaeva, Richard Rheingans, Fuminaka Sugauchi and Anis Khan and has published in prestigious journals such as PLoS ONE, Scientific Reports and The Journal of Infectious Diseases.

In The Last Decade

Erkin Musabaev

34 papers receiving 298 citations

Peers

Erkin Musabaev

HEPAT

EPIDE

PARAS

S. Zakaria Egypt

Armin Baillot Germany

Theophilus Adiku Ghana

Soraya Sharaf Egypt

Christevy Vouvoungui Republic of the Congo

Chipo Berejena Zimbabwe

Phimpha Paboriboune France

Yvonnick Guillois France

Sarah Cristina Fontes Vieira Brazil

Nadia Nisar Pakistan

S. Zakaria Egypt

Erkin Musabaev

297 ×1.5

HEPAT

151 ×1.0

EPIDE

148 ×1.5

54 ×1.5

PARAS

11 ×0.3

Citations per year, relative to Erkin Musabaev Erkin Musabaev (= 1×) peers S. Zakaria

Countries citing papers authored by Erkin Musabaev

Since Specialization

Citations

This map shows the geographic impact of Erkin Musabaev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erkin Musabaev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erkin Musabaev more than expected).

Fields of papers citing papers by Erkin Musabaev

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erkin Musabaev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erkin Musabaev. The network helps show where Erkin Musabaev may publish in the future.

Co-authorship network of co-authors of Erkin Musabaev

This figure shows the co-authorship network connecting the top 25 collaborators of Erkin Musabaev. A scholar is included among the top collaborators of Erkin Musabaev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erkin Musabaev. Erkin Musabaev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

He, Chengyi, Yunfei Chen, David Fisher, et al.. (2025). Dihydromyricetin: an emerging compound with comprehensive effects on multiple systems. Frontiers in Pharmacology. 15. 1488003–1488003. 3 indexed citations

Li, Jiahuan, et al.. (2025). The effects of cynaroside on lipid metabolism and lipid-related diseases: a mechanistic overview. Frontiers in Pharmacology. 16. 1648614–1648614.

Zhang, Hao, Yiping Dang, Yuan-Jin Guo, et al.. (2025). Lunasin: Exploring the pharmacological potential of a soy-derived peptide. European Journal of Medicinal Chemistry. 302(Pt 2). 118317–118317.

Xie, Jinbo, et al.. (2025). Association of platelet to albumin ratio with metabolic dysfunction-associated steatotic liver disease based on the National Health and Nutrition Survey 2017–2018. Scientific Reports. 15(1). 10573–10573. 2 indexed citations

Khetsuriani, Nino, et al.. (2025). Prevalence of chronic hepatitis B virus infection among children in Uzbekistan: Impact of vaccination. Vaccine. 48. 126743–126743.

Musabaev, Erkin, et al.. (2024). Optimizing Human Papillomavirus (HPV) Screening: Urine Sample Analysis and Associated Factors in Uzbekistan. Cureus. 16(9). e69816–e69816.

Fisher, David, et al.. (2024). Clinical factors associated with invasive pulmonary aspergillosis in patients with severe fever with thrombocytopenia syndrome: analysis of a 6-year clinical experience. Frontiers in Microbiology. 15. 1448710–1448710. 1 indexed citations

Кан, Н. Е., et al.. (2024). Identification of CXCL9 chemokine as a potential biomarker for assessing clinical severity in COVID-19 patients. The Journal of Infection in Developing Countries. 18(5). 672–678.

Chen, Lin, et al.. (2024). Cell Cycle-Related LncRNA-Based Prognostic Model for Hepatocellular Carcinoma: Integrating Immune Microenvironment and Treatment Response. Current Medical Science. 44(6). 1217–1231.

10.

Liu, Cuiling, et al.. (2024). The History of Controlling and Treating Infectious Diseases in Ancient China. Current Medical Science. 44(1). 64–70. 2 indexed citations

11.

Mazhnaya, Alyona, Krestina Brigida, Shokhista Bakieva, et al.. (2024). Barriers and facilitators to viral hepatitis testing in Uzbekistan: scoping qualitative study among key stakeholders, healthcare workers, and the general population. BMC Public Health. 24(1). 1482–1482. 1 indexed citations

12.

Liu, Cuiling, David Fisher, Erkin Musabaev, et al.. (2024). Therapeutic potential of natural products in schistosomiasis-associated liver fibrosis. Frontiers in Pharmacology. 15. 1332027–1332027. 3 indexed citations

13.

Musabaev, Erkin, Chris Estes, Shakhlo Sadirova, et al.. (2023). Viral hepatitis elimination challenges in low‐ and middle‐income countries—Uzbekistan Hepatitis Elimination Program (UHEP). Liver International. 43(4). 773–784. 10 indexed citations

14.

Musabaev, Erkin, et al.. (2020). Prevalence of Antiretroviral Drug Resistance Mutations Among Pretreatment and Antiretroviral Therapy-Failure HIV Patients in Uzbekistan. AIDS Research and Human Retroviruses. 37(1). 38–43. 3 indexed citations

15.

Colombo, Massimo, et al.. (2019). Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions. World Journal of Gastroenterology. 25(29). 3897–3919. 3 indexed citations

16.

Sugiyama, Masaya, Naohiko Masaki, Nao Nishida, et al.. (2014). IL28B Polymorphisms and Clinical Implications for Hepatitis C Virus Infection in Uzbekistan. PLoS ONE. 9(3). e93011–e93011. 10 indexed citations

17.

Kurbanov, Fuat, Yasuhito Tanaka, Anis Khan, et al.. (2007). Detection of hepatitis C virus natural recombinant RF1_2k/1b strain among intravenous drug users in Uzbekistan. Hepatology Research. 38(5). 457–464. 42 indexed citations

18.

Musabaev, Erkin, et al.. (2007). Effect of hygiene promotion on the risk of reinfection rate of intestinal parasites in children in rural Uzbekistan. Transactions of the Royal Society of Tropical Medicine and Hygiene. 101(6). 564–569. 44 indexed citations

19.

Isakbaeva, Elmira T., Erkin Musabaev, Lynn Antil, et al.. (2006). Rotavirus disease in Uzbekistan: Cost-effectiveness of a new vaccine. Vaccine. 25(2). 373–380. 58 indexed citations

20.

Beutels, Philippe, et al.. (2000). The Disease Burden of Hepatitis B in Uzbekistan. Journal of Infection. 40(3). 234–241. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact